The insider selling is modest in size relative to market cap and may reflect routine diversification or tax planning, especially given the CEO's large gift. However, the concentration of sales by the CEO and CFO on the same day warrants monitoring for any upcoming news (e.g., earnings, pipeline update). The stock has historically drifted higher after neutral reports, but this cluster is a sell, not a buy — treat as noise unless additional negative catalysts emerge.
Price Chart
Executive Summary
Three top executives at Corcept Therapeutics (CEO, CFO, and a senior officer) sold a total of $7.59M in open-market shares over a 7-day window, including a $2.80M sale by the CFO and an $895K sale by the CEO. While the dollar amount is modest relative to the $7.6B market cap (~0.1%), the cluster involves the C-suite and follows a large non-cash gift by the CEO, raising questions about insider sentiment ahead of any upcoming catalyst.
Key Financial Metrics
Key Facts
- CEO Joseph Belanoff sold 12,837 shares for $895K on June 1, 2026.
- CFO Atabak Mokari sold 40,000 shares for $2.80M on June 1, 2026.
- Sean Maduck sold 21,069 shares for $1.48M on June 1, 2026, plus an earlier sale of 54.6K shares for $3.57M on May 27.
- Total open-market sales by the cluster: ~$7.59M, representing ~0.1% of market cap.
- CEO also gifted 300,000 shares (non-cash) on May 29, 2026.
- Non-cash transactions (tax withholding, option exercises, grants) were also filed but have zero economic impact.
- The cluster includes C-suite (CEO, CFO) and senior officers, but the dollar amount is proportional to routine diversification.
- Historical performance on CORT shows strong positive drift at T+20 across prior neutral reports, but this is a sell cluster.
Financial Impact
Total insider sales of $7.59M, or ~0.1% of Corcept's $7.6B market cap — a modest amount that does not signal material bearish conviction.
Risk Factors
- Insider sales could precede negative clinical or regulatory news, though dollar amounts are too small to be definitive.
- CEO's large gift may indicate estate planning or a prelude to further selling.
- The cluster's timing near the end of a quarter could align with blackout window openings, reducing informational content.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CORT-1780528855900 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 28, 2026 5w ago | Insider Cluster | $113.88 $115.63 | ▲ +1.54% | ▲ +1.28% | $116.49 (+2.29%) |
Aug 28, 2026 5w ago | Insider Cluster | $113.88 $116.10 | ▲ +1.95% | ▲ +1.44% | $116.49 (+2.29%) |
Aug 27, 2026 5w ago | Insider Cluster | $116.93 $117.00 | ▲ +0.06% | ▲ +0.16% | $116.49 (−0.38%) |
Aug 20, 2026 6w ago | Insider Cluster | $121.05 $114.86 | ▼ −5.11% | ▼ −5.11% | $116.49 (−3.77%) |
Aug 18, 2026 6w ago | Insider Cluster | $118.10 $111.85 | ▲ +5.29% | ▲ +4.30% | $116.49 (+1.36%) |
Aug 12, 2026 7w ago | Insider Cluster | $112.18 $114.92 | ▲ +2.44% | ▲ +4.34% | $116.49 (+3.84%) |
Aug 12, 2026 7w ago | Insider Cluster | $112.18 $114.92 | ▲ +2.44% | ▲ +4.34% | $116.49 (+3.84%) |
Aug 6, 2026 8w ago | Insider Cluster | $110.77 $111.62 | ▲ +0.77% | ▲ +1.16% | $116.49 (+5.16%) |
Aug 5, 2026 8w ago | Insider Cluster | $107.95 $112.80 | ▲ +4.49% | ▲ +3.89% | $116.49 (+7.91%) |
Jul 23, 2026 10w ago | Court Ruling | $96.66 $121.05 | ▲ +25.23% | ▲ +21.92% | $116.49 (+20.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access